BERWYN, PA and DUBLIN, Ireland — AscellaHealth has announced significant additions to its executive team with the promotion of Gillian Molloy to Vice President of Market Access and the appointment of Alexis Moss as EU/U.K. Director of Business Development. These strategic appointments aim to enhance the company’s global capabilities and strengthen its ability to deliver comprehensive solutions for product commercialization, market access, patient support, and more.
Bill Oldham, chairman and president of AscellaHealth, expressed enthusiasm about the new appointments: “We are delighted to have Gillian and Alexis in these key leadership roles at AscellaHealth. Their combined expertise and knowledge will greatly enhance our global capabilities. This strategic expansion of our team reflects our continued commitment to providing exceptional services to our life sciences partners, while ensuring that patients worldwide with complex, chronic, and rare conditions can access the therapies they need.”
Gillian Molloy, with over 20 years of experience in the life sciences industry, has previously served as Director of Market Access at AscellaHealth. Her extensive background includes roles at Baxter, Novartis Oncology, AstraZeneca, and UnitedHealth Group across European and US markets. In her new role, Molloy will spearhead strategic market access initiatives globally, focusing on establishing pricing and reimbursement sustainability. “I am thrilled to take on these new responsibilities at this exciting, pivotal time in AscellaHealth’s growth trajectory and look forward to advancing its position in transforming patient care,” said Molloy.
Alexis Moss joins AscellaHealth with more than two decades of experience in the healthcare sector, having held strategic positions at Pfizer, AAH Pharmaceuticals, and Lloyds Pharmacy Clinical Home Care. Her role will involve building partnerships with the life sciences industry to support growth. Moss stated, “Joining AscellaHealth presents a unique and exciting opportunity to leverage my corporate experience in a dynamic, agile environment. I am eager to utilize my background to forge impactful partnerships and execute innovative business development solutions across Europe, the U.K., and beyond.”
These appointments aim to expand AscellaHealth’s international footprint and enhance the scope of its partnerships within the specialty pharmaceutical industry. The enhanced executive team is poised to drive the company’s strategic initiatives and contribute to its mission of optimizing therapeutic outcomes and streamlining the commercialization process for manufacturers.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.